Founded in 1954, Straumann (STMN) is Switzerland’s leading producer and provider of restorative, implant and regenerative dentistry services. The company develops and manufactures dental implants, instruments, bone and tissue regeneration materials to prevent tooth loss. Straumann has 6 production sites for implants and biomaterials in Europe and the United States. From the first one-stage dental implant in 1974, today the company has placed 15 million implants worldwide. The Staumann Group employs 3,400 people and operates in more than 70 countries. Headquartered in Basel, Switzerland, the Straumann Holding share price (STMN) is set and traded on the SIX Swiss Exchange.